Jaspreet S. Brar, MD, MPH

Original Research

Benefits of Ashwagandha for Schizophrenia

July 10, 2018

Read a study on how a extract of Ashwagandha (Withania somnifera), when added to antipsychotic medications to patients with schizophrenia.

Letter to the Editor

Dr Chengappa and Colleagues Reply

May 27, 2015

Original Research

Varenicline for Smoking Cessation in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Study

June 10, 2014

Original Research

Randomized Placebo-Controlled Adjunctive Study of an Extract of Withania somnifera for Cognitive Dysfunction in Bipolar Disorder

November 15, 2013

Letter to the Editor

"Reply to Increasing Energy Expenditure Is Important to Enchance Management of Antipsychotic-Associated Weight Gain."

July 15, 2005

Original Research

Effects of Behavioral Therapy on Weight Loss in Overweight and Obese Patients With Schizophrenia or Schizoaffective Disorder

February 15, 2005

Original Research

Bupropion Sustained Release as a Smoking Cessation Treatment in Remitted Depressed Patients Maintained on Treatment With Selective Serotonin Reuptake Inhibitor Antidepressants

July 1, 2001

Original Research

Risperidone Use at a State Hospital: A Clinical Audit 2 Years After the First Wave of Risperidone Prescriptions

June 30, 1999